Philadelphia, Pennsylvania--(Newsfile Corp. - July 15, 2024) - Kaskela Law LLC announces that it is investigating Nautilus Biotechnology, Inc. (NASDAQ: NAUT) on behalf of the company's former employees.
On July 15, 2021, Arya Sciences Acquisition Corp. III ("Arya"), a publicly traded special purpose acquisition ("SPAC") company, announced that Arya's stockholders had approved of an acquisition of privately held Nautilus Biotechnology, Inc. ("Legacy Nautilus"). Arya also announced that, upon the closing of the acquisition, the combined company would continue to be named Nautilus Biotechnology ("Nautilus") and its common stock would start trading under ticker symbol NASDAQ: NAUT.
In connection with the closing of the acquisition, many of Legacy Nautilus's executives and employees had their previously held shares/stock options of privately held Legacy Nautilus converted into shares of publicly traded Nautilus (NASDAQ: NAUT). The investigation seeks to determine whether this share conversion was done in a fair manner and in accordance with the securities laws, or whether former Legacy Nautilus shareholders were financially harmed in connection with the conversion.
Former Legacy Nautilus employees who had their shares/stock options of privately held Legacy Nautilus converted into publicly traded shares of Nautilus (NASDAQ: NAUT) are encouraged to contact Kaskela Law LLC (D. Seamus Kaskela, Esq. or Adrienne Bell, Esq.) for additional information about this investigation and their legal rights and options at (484) 229 - 0750 or (888) 715 - 1740, or by clicking on the following link (or if necessary, by copying and pasting the link into your browser):
https://kaskelalaw.com/case/nautilus-biotechnology/
Kaskela Law LLC exclusively represents investors in securities fraud, corporate governance, and merger & acquisition litigation on a contingent basis. For additional information about Kaskela Law LLC please visit www.kaskelalaw.com.
This notice may constitute attorney advertising in certain jurisdictions.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/216462
